DNA Tests May Aid Diagnosis of CNS Infections

This article originally appeared here.
Share this content:
DNA Tests May Aid Diagnosis of CNS Infections
DNA Tests May Aid Diagnosis of CNS Infections

FRIDAY, June 24, 2016 (HealthDay News) -- Genetic testing may help diagnose or rule out central nervous system (CNS) infections, according to research published online June 13 in Neurology: Neuroimmunology & Neuroinflammation.

The study included 10 patients, aged 16 to 68, with signs of CNS infection, including fever, weakness in limbs, partial paralysis, numbness, headache, or seizures. The researchers took brain or spinal cord biopsies and sequenced the DNA in the tissue. They looked for evidence of bacteria, viruses, and other pathogens that could cause infection.

"By incorporating modern genetic sequencing techniques into pathology diagnostics, we were able to investigate the potential presence of infection in 10 subjects and found appropriate explanations of clinical problems in eight out of 10 patient cases examined in this study," study author Carlos Pardo-Villamizar, M.D., an associate professor of neurology at Johns Hopkins University in Baltimore, said in a university news release.

"We hope to develop this technique further as a way to bring the diagnosis rate of inflammatory brain disorders and infections closer to 100 percent so we can treat patients more effectively," Pardo-Villamizar added.

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease


More in Home

Insulin Glargine, Lixisenatide Combo Beneficial in T2DM

Insulin Glargine, Lixisenatide Combo Beneficial in T2DM

Improved achievement of glycemic targets, reduced body weight

European, American Guidelines Lead to Different Recs for Statins

European, American Guidelines Lead to Different Recs for ...

Quantification of CAC score can improve stratification for those at high, low risk for events

Hyperbaric O2 Therapy Effective in Maxillary Osteoradionecrosis

Hyperbaric O<sub>2</sub> Therapy Effective in Maxillary Osteoradionecrosis

Positive clinical outcome with HBOT for 85.7 percent of patients with maxillary bone osteoradionecrosis

is free, fast, and customized just for you!

Already a member?

Sign In Now »